Author:
Zurawski Jonathan,Weiner Howard L.
Reference210 articles.
1. Serum GFAP as a biomarker for disease severity in multiple sclerosis [published correction appears in Scientific Reports. June 5, 2019, 9(1), 8433];Abdelhak;Scientific Reports,2018
2. Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases;Absinta;Neurology,2017
3. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis;Absinta;Nature,2021
4. Identification of chronic active multiple sclerosis lesions on 3T MRI;Absinta;AJNR American Journal of Neuroradiology,2018
5. Association of chronic active multiple sclerosis lesions with disability in vivo [published correction appears in JAMA Neurology. December 1, 2019, 76(12), 1520];Absinta;JAMA Neurology,2019